BIODESIX INC
Company Stats
- Market Cap
- $314.7M
- as of Sep 30, 2026
- Shares Outstanding
- 10.6M
- Free Float
- 54.8%
Income Statement
- Revenue
- $88.5M
- Operating Income
- -$27.9M
- Net Income
- -$35.3M
- EBITDA
- -$22.2M
- Revenue Growth, 3Y
- 32.3%
- FCF Margin, 3Y Avg
- -64.2%
- FCF Margin, Worst Year
- -93.3%
Cash Flow
- Free Cash Flow
- -$23.5M
- FCF Yield
- -7.5%
- Owner FCF Yield
- -8.8%
Balance Sheet
- Cash & Equivalents
- $19.0M
Returns & Capital
- SBC, 3Y Avg
- $5.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $88.5M | -$23.5M | -26.6% |
| FY2024 | $71.3M | -$51.9M | -72.7% |
| FY2023 | $49.1M | -$45.8M | -93.3% |
| FY2022 | $38.2M | -$48.3M | -126.3% |
| FY2021 | $54.5M | -$30.5M | -55.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges